EYPT
EyePoint, Inc.
Biotechnology · Healthcare · United States
0.35
close · 2026-10-30
value
6
cheaper than peers6
quality
31
stronger fundamentals31
ranked against
Biotechnology (commercial)
value
quality
162 peerswide variation
Value inputs
| measure | company | vs peers |
| price to book | 0.18× | 98 |
| cash flow yield, 2 years ago | -5.5% | 60 |
| price to sales | 10.48× | 52 |
| cash flow yield, 3 years ago | -229.9% | 5 |
| earnings yield, 2 years ago | -522.4% | 4 |
| cash flow yield, 1 year ago | -446.0% | 2 |
| earnings yield, 1 year ago | -665.9% | 2 |
| cash flow yield, latest year | -833.2% | 1 |
| earnings yield, 3 years ago | -786.5% | 0 |
| earnings yield, latest year | -909.9% | 0 |
10 of 12 measures available
Quality inputs
| measure | company | vs peers |
| revenue growth | 161.7% | 82 |
| operating margin | -450.7% | 35 |
| debt to equity | 46.8% | 32 |
| return on equity | -148.7% | 15 |
4 of 4 measures available
Facts
| market cap | $29M |
| free cash flow | -$168.7M |
| employees | 214 |
| first trade | 2005-01-27 |
| next earnings | 2026-08-05 |
| fundamentals updated | 2026-08-06 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -3.17 | -2.32 | -1.82 | -2.74 |
| free cash flow | -$243.4M | -$130.3M | -$1.6M | -$67.2M |
| net income | -$232.0M | -$130.9M | -$70.8M | -$102.3M |
| revenue | $31.4M | $43.3M | $46.0M | $41.4M |
| unusual items | $0 | $0 | -$1.3M | -$22.3M |